PT - JOURNAL ARTICLE AU - R Sankaranarayanan AU - N Hartshorne-Evans AU - S Redmond-Lyon AU - J Wilson AU - H Essa AU - A Gray AU - L Clayton AU - C Barton AU - FZ Ahmed AU - C Cunnington AU - DK Satchithananda AU - C Murphy TI - The Impact of COVID-19 on the Management of Heart Failure -A United Kingdom Patient Questionnaire Study AID - 10.1101/2020.10.03.20205328 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.03.20205328 4099 - http://medrxiv.org/content/early/2020/10/06/2020.10.03.20205328.short 4100 - http://medrxiv.org/content/early/2020/10/06/2020.10.03.20205328.full AB - Aim The coronavirus disease 2019 (COVID-19) pandemic has created significant challenges to healthcare globally, necessitating rapid restructuring of service provision. This questionnaire survey was conducted amongst adult heart failure (HF) patients in the United Kingdom (UK), to understand the impact of COVID-19 upon HF services.Methods and Results The survey was conducted by the Pumping Marvellous Foundation (PMF), a UK HF patient charity. “Survey Monkey” was used to disseminate the questionnaire in the PMF’s online patient group and in 10 UK hospitals (out-patient hospital and community HF clinics). 1050 responses were collected (693/1050-66% women); 55% (579/1050) were aged over 60 years. Anxiety level was significantly higher regarding COVID19 (mean 7±2.5 on anxiety scale of 0 to 10) compared to anxiety regarding HF (6.1±2.4; p<0.001). Anxiety was higher amongst patients aged ≤60 years about HF (6.3±2.2 versus 5.9±2.5 in those aged >60 years; p=0.005) and COVID-19 (7.3±2.3 versus 6.7±2.6 those aged >60 years; p<0.001). 65% respondents (686/1050) reported disruption to HF appointments (cancellation or postponement) during the lockdown period. 37% reported disruption to medication prescription services and 34% reported inability to access their HF teams promptly. 32% expressed reluctance to attend hospital (25% stated they would only attend hospital if there was no alternative and 7% stated that they would not attend hospital at all).Conclusions The COVID-19 pandemic has caused significant anxiety amongst HF patients regarding COVID-19 and HF. Cancellation or postponement of scheduled clinic appointments, investigations, procedures, prescription and monitoring services were implicated as sources of anxiety.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All necessary ethical guidelines have been followed. Institutional ethics approval obtained from the advisory board of the Patient-Led Charity Pumping Marvellous Foundation and the audit and research department at Liverpool University Hospitals NHS Foundation TrustAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data were generated at the Pumping Marvellous Foundation by analysis of data from https://www.surveymonkey.co.uk/r/K2DSBPZ. Derived data supporting the findings of this study are available from the corresponding author [RS] on request https://www.surveymonkey.co.uk/r/K2DSBPZ